To assess the implication of AXL in CML cell protection, we next overexpressed a wild-type (AXL-WT) or a kinase deleted mutant of AXL (AXL-DN) in IM-S K562 cells. The gene discussed is AXL; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.